Background: Intravenous (IV) anti-hypertensive medications such as labetalol and hydralazine are commonly administered as needed or “prn” to asymptomatic patients in the hospital with elevated blood pressure. This practice may lead to patient harm (such as hypotension or stroke) and increased costs without any known benefit. Much attention has been focused on this issue in […]